COMP Stock Analysis: Compass | NYSE
Real Estate Services | NYSE, USA | Market Cap: 8.757m USD | 12M Return: 72.4% | Charts, Fundamentals & Technical Analysis
Avg Turnover: 168M
Qual. Beats: 1
Rev. Trend: 93.5%
Qual. Beats: 0
Warnings
Tailwinds
Seasonality 5.2 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
Compass, Inc. (NYSE: COMP) is a US-based company that provides an end-to-end technology platform for the residential real estate industry. Its core offering, the Compass Platform, is a cloud-based software suite that combines customer relationship management, marketing, client service, and brokerage functions, and is complemented by title, escrow, and mortgage services. Beyond its proprietary platform, the company operates the Christies International Real Estate (CIRE) affiliate network, offers tools and services under the Anywhere brand, and runs Compass Concierge, which advances capital to home sellers for pre-listing improvements. The company was founded in 2012 in New York, originally as Urban Compass, and adopted its current name in January 2021.
Compass operates as both a software provider and a licensed residential real estate brokerage, a hybrid model that distinguishes it from pure-play real estate technology vendors. The US residential brokerage industry it competes in remains highly fragmented, historically dominated by independent agents and small local firms, which has been a key factor driving consolidation and technology adoption across the sector.
- Mortgage rate cuts likely to reignite existing home sales volume
- NAR commission settlement reshapes buyer-side revenue and agent retention
- Agent count growth drives market share gains and transaction volume
| Net Income: 14.2m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.00 > 0.02 and ΔFCF/TA -7.55 > 1.0 |
| NWC/Revenue: -2.39% < 20% (prev -3.66%; Δ 1.26% < -1%) |
| CFO/TA 0.00 > 3% & CFO 36.6m > Net Income 14.2m |
| Net Debt/EBITDA: error (EBITDA <= 0) |
| Current Ratio: 0.84 > 1.5 & < 3 |
| Outstanding Shares: last quarter (572.0m) vs 12m ago 3.97% < -2% |
| Gross Margin: 19.13% > 18% (prev 16.33%; Δ 2.80% > 0.5%) |
| Asset Turnover: 172.0% > 50% (prev 384.5%; Δ -212.4% > 0%) |
| Interest Coverage Ratio: -8.02 > 6 (EBIT TTM -350.6m / Interest Expense TTM 43.7m) |
| A: -0.02 (Total Current Assets 1.06b - Total Current Liabilities 1.26b) / Total Assets 8.12b |
| B: -0.33 (Retained Earnings -2.71b / Total Assets 8.12b) |
| C: -0.07 (EBIT TTM -350.6m / Avg Total Assets 4.83b) |
| D: 0.53 (Book Value of Equity 2.82b / Total Liabilities 5.29b) |
| Altman-Z'' = -1.18 = CCC |
| DSRI: 1.26 (Receivables 180.0m/102.2m, Revenue 8.31b/5.93b) |
| GMI: 0.85 (GM 16.33% / 19.13%) |
| AQI: 1.57 (AQ_t 0.75 / AQ_t-1 0.48) |
| SGI: 1.40 (Revenue 8.31b / 5.93b) |
| TATA: -0.00 (NI 14.2m - CFO 36.6m) / TA 8.12b) |
| Beneish M = -2.32 (Cap -4..+1) = BBB |
As of July 14, 2026, the stock is trading at USD 11.50 with a total of 10,905,201 shares traded. Over the past week, the price has changed by -11.47%, over one month by +25.82%, over three months by +61.29% and over the past year by +72.41%.
Current recommended Stop Loss: 10.50 (which is 8.7% or 1.5 ATR below the current price).
Compass has received a consensus analysts rating of 3.67. Therefore, it is recommended to hold COMP.
- StrongBuy: 2
- Buy: 2
- Hold: 5
- Sell: 0
- StrongSell: 0
| Analysts Target Price | 13.4 | 16.7% |
P/E Trailing = 586.0
P/E Forward = 22.1239
P/S = 1.0538
P/B = 3.1052
Revenue TTM = 8.31b USD
EBIT TTM = -350.6m USD
EBITDA TTM = -103.7m USD
Long Term Debt = 3.14b USD (from longTermDebt, last quarter)
Short Term Debt = 335.0m USD (from shortTermDebt, last quarter)
Debt = 4.85b USD (from shortLongTermDebtTotal, last quarter) + Leases 775.0m
Net Debt = 4.36b USD (calculated: Debt 4.85b - CCE 484.0m)
Enterprise Value = 13.1b USD (8.76b + Debt 4.85b - CCE 484.0m)
Interest Coverage Ratio = -8.02 (Ebit TTM -350.6m / Interest Expense TTM 43.7m)
EV/FCF = 830.3x (Enterprise Value 13.1b / FCF TTM 15.8m)
FCF Yield = 0.12% (FCF TTM 15.8m / Enterprise Value 13.1b)
FCF Margin = 0.19% (FCF TTM 15.8m / Revenue TTM 8.31b)
Net Margin = 0.17% (Net Income TTM 14.2m / Revenue TTM 8.31b)
Gross Margin = 19.13% ((Revenue TTM 8.31b - Cost of Revenue TTM 6.72b) / Revenue TTM)
Gross Margin QoQ = 25.74% (prev 10.41%)
Tobins Q-Ratio = 1.62 (Enterprise Value 13.1b / Total Assets 8.12b)
Interest Expense / Debt = 0.90% (Interest Expense 43.7m / Debt 4.85b)
Taxrate = 21.0% (US federal default 21%)
NOPAT = -277.0m (EBIT -350.6m * (1 - 21.00%)) [loss with tax shield]
Current Ratio = 0.84 (Total Current Assets 1.06b / Total Current Liabilities 1.26b)
Debt / Equity = 1.72 (Debt 4.85b / totalStockholderEquity, last quarter 2.82b)
Debt / EBITDA = -42.06 (negative EBITDA) (Net Debt 4.36b / EBITDA -103.7m)
Debt / FCF = 276.1 (Net Debt 4.36b / FCF TTM 15.8m)
Total Stockholder Equity = 1.27b (last 4 quarters mean from totalStockholderEquity)
RoA = 0.29% (Net Income 14.2m / Total Assets 8.12b)
RoE = 1.11% (Net Income TTM 14.2m / Total Stockholder Equity 1.27b)
RoCE = -7.94% (EBIT -350.6m / Capital Employed (Equity 1.27b + L.T.Debt 3.14b))
RoIC = -4.09% (negative operating profit) (NOPAT -277.0m / Invested Capital 6.77b)
WACC = 7.47% (E(8.76b)/V(13.6b) * Re(11.21%) + D(4.85b)/V(13.6b) * Rd(0.90%) * (1-Tc(0.21)))
Discount Rate = 11.21% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: 80.90 | Cagr: 7.73%
[DCF] Terminal Value 73.10% ; FCFF base≈57.2m ; Y1≈50.2m ; Y5≈40.6m
[DCF] Fair Price = N/A (negative equity: EV 651.0m - Net Debt 4.36b = -3.71b; debt exceeds intrinsic value)
EPS Correlation: N/A | EPS CAGR: N/A | SUE: 4.0 | # QB: 1
Revenue Correlation: 93.51 | Revenue CAGR: 18.96% | SUE: 0.12 | # QB: 0
EPS current Quarter (2026-06-30): EPS=0.26 | Chg30d=-12.47% | Revisions=-17% | Analysts=3
EPS next Quarter (2026-09-30): EPS=0.20 | Chg30d=-6.80% | Revisions=-17% | Analysts=3
EPS current Year (2026-12-31): EPS=0.84 | Chg30d=+56.11% | Revisions=+17% | GrowthEPS=+169.3% | GrowthRev=+100.7%
EPS next Year (2027-12-31): EPS=0.78 | Chg30d=-9.39% | Revisions=-17% | GrowthEPS=-6.6% | GrowthRev=+8.7%
[Analyst] Revisions Ratio: -13% (up=5, down=7)